Xiamen, China

Wei-lin Chen

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Neuboron Therapy System Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei-lin Chen. Retrieved from https://idiyas.com/inventor/wei-lin-chen-tudjg309

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wei-lin Chen and Neutron Capture Therapy Innovation.

Introduction

Wei-lin Chen is an inventor based in Xiamen, China. His patent work includes an apparatus designed to support neutron capture therapy, a treatment approach that uses a neutron beam and boron within an irradiated object.

Latest Patents

Chen is associated with one patent, titled “Neutron Capture Therapy Apparatus.” The invention describes an apparatus that irradiates an object with a neutron beam at a preset dose. The beam enters the object and undergoes a nuclear reaction with boron present there. A correction system adjusts the preset neutron dose.

Career Highlights

Chen’s listed patent activity focuses on neutron capture therapy technology. He is associated with Neuboron Therapy System Ltd., a company working in the therapy systems field.

Collaborations

The available information connects Chen’s patent work with Neuboron Therapy System Ltd. It does not specify additional collaborators or institutions.

Conclusion

Wei-lin Chen’s patent contribution centers on a neutron capture therapy apparatus with a system for correcting the preset neutron dose, reflecting a focused effort in therapeutic technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…